Opportunity

SAM #A75N98026R00138

Extension of Ordering Period for NIH NINDS Preclinical Testing and Toxicology IDIQ Contracts

Buyer

NIH Office of Logistics and Acquisition Operations

Posted

September 17, 2026

Identifier

A75N98026R00138

NAICS

541715

This opportunity involves the extension of ordering periods for four IDIQ contracts supporting NIH's NINDS Blueprint Neurotherapeutics Network Preclinical Testing and Toxicology Program. - Government Buyer: - National Institutes of Health (NIH) - Office of Acquisition and Logistics Management (OALM) - Office of Logistics and Acquisition Operations (OLAO) - OEMs/Vendors: - SRI International - Southern Research - IIT Research Institute (IITRI) - University of Illinois Chicago, Toxicology Research Laboratory (TRL) - Products/Services Requested: - Preclinical pharmacokinetics, toxicology, and safety studies - GLP-IND-enabling toxicology studies - Research services supporting IND applications (including safety pharmacology, genotoxicity, in vitro ADMET assays) - Notable Requirements: - No new products or services are being procured; this is a no-cost extension - Ordering period extended by one year to bridge to a follow-on competitive acquisition - No changes to contract terms, conditions, scope, or ceiling value - Task orders issued before expiration may continue until completion - Contract Numbers: - HHSN271201600006I - HHSN271201600007I - 75N95021D00026 - 75N95022D00026 - The extension ensures continuity of critical IND-enabling research services until the next competitive award cycle

Description

NINDS Blueprint Neurotherapeutics Network (BPN) extended the ordering period of four (4) existing Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded under the BPN Preclinical Testing and Toxicology Program (PTTP), with the contractors listed below. This action extends the ordering period by one year, from September 13, 2026, through September 12, 2027. This is a no-cost modification; no other changes to the contracts' terms, conditions, scope, or ceiling value are being made.

SRI International      

HHSN271201600006I

Southern Research 

HHSN271201600007I            

IIT Research Institute (IITRI)

75N95021D00026

University of Illinois Chicago, Toxicology Research Laboratory (TRL)             

75N95022D00026

Please refer to the attached justification for additional information.

View original listing